922 related articles for article (PubMed ID: 12536355)
1. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
3. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
6. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
Hayes FJ; Taylor AE; Martin KA; Hall JE
J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
[TBL] [Abstract][Full Text] [Related]
7. Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients.
Moret M; Stettler R; Rodieux F; Gaillard RC; Waeber G; Wirthner D; Giusti V; Tappy L; Pralong FP
Neuroendocrinology; 2009; 89(2):131-9. PubMed ID: 18832802
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
9. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
10. The gonadotropic axis in hyperandrogenic adolescents.
Taylor AE
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1281-4. PubMed ID: 11117670
[TBL] [Abstract][Full Text] [Related]
11. The role of changing pulse frequency in the regulation of ovulation.
Marshall JC; Griffin ML
Hum Reprod; 1993 Nov; 8 Suppl 2():57-61. PubMed ID: 8276970
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
Apter D; Bützow TL; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
[TBL] [Abstract][Full Text] [Related]
13. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
Sagnella F; Apa R; Guido M; Villa P; Spadoni V; Miceli F; Lanzone A
Fertil Steril; 2009 May; 91(5):1857-63. PubMed ID: 18538325
[TBL] [Abstract][Full Text] [Related]
14. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
15. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
[TBL] [Abstract][Full Text] [Related]
16. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic dysfunction.
Marshall JC; Eagleson CA; McCartney CR
Mol Cell Endocrinol; 2001 Oct; 183(1-2):29-32. PubMed ID: 11604221
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic-pituitary-ovarian function in menstruating women with Turner syndrome (45,X).
Page LA; Beauregard LJ; Bode HH; Beitins IZ
Pediatr Res; 1990 Nov; 28(5):514-7. PubMed ID: 2255575
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation.
Reame NE; Sauder SE; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1985 Nov; 61(5):851-8. PubMed ID: 3900122
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
